672 results on '"Seif, Alix"'
Search Results
102. 77 - Proteomic Analyses Reveal Molecular Connections That Support the Clinical Association of Cystitis with Thrombotic Microangiopathy in Pediatric Transplant Recipients
103. Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
104. Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment.
105. Differential Depletion of Bone Marrow Resident B-ALL after Systemic Administration of Endosomal TLR Agonists
106. Transient atypical monocytosis after α/β T‐cell‐depleted haploidentical hematopoietic stem cell transplantation
107. The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation
108. Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group
109. Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS)
110. 1762. Genotype Prevalence and Molecular Characteristics of Human Adenovirus in Pediatric Hematopoietic Stem Cell Transplant Recipients
111. Outcomes of human adenovirus infection and disease in a retrospective cohort of pediatric solid organ transplant recipients
112. Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events
113. 431 - Extracellular Vesicle Proteome Reflects BK Viral Infection and Cystitis Status in Pediatric Hematopoietic Stem Cell Transplant (HSCT) Recipients
114. 167 - Chimerism Trends in Pediatric Patients Transplanted for Hematologic Malignancies
115. The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation.
116. Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia
117. Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
118. A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort
119. Using Administrative Data to Identify Relapse and Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Lymphoblastic Leukemia (ALL): Validation at Two Centers and Incidence Estimation in a National Cohort
120. Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study
121. Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia
122. Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study
123. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
124. Veno-occlusive disease after high-dose busulfan–melphalan in neuroblastoma
125. Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high-risk neuroblastoma using a national administrative database
126. Outcomes of Human Adenovirus Infection and Disease in a Retrospective Cohort of Pediatric Hematopoietic Cell Transplant Recipients
127. Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia*
128. Using administrative laboratory result data to describe adverse events.
129. The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non‐Hodgkin lymphoma
130. BK Viremia is Common in Children after Allogeneic Hematopoietic Cell Transplant
131. Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia
132. Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232
133. Nutritional risk factors predict severe acute graft-versus-host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation
134. Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database
135. Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease
136. Complications preceding early deaths in Black and White children with acute myeloid leukemia
137. Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
138. The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL).
139. IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life
140. Single-Agent Calcineurin-Inhibitor (CNI) for the Prevention of Graft Versus Host Disease (GVHD) in Pediatric Patients Undergoing HLA-Identical Sibling Bone Marrow Transplant (BMT)
141. Outcomes of Human Adenovirus Infection and Disease in a Retrospective Cohort of Pediatric Hematopoietic Cell Transplant Recipients.
142. Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment.
143. Abstract A51: Early-life infection delays B cell precursor leukemia onset in Eu-Ret mice via an IL-23-dependent depletion of leukemia-initiating cells
144. Immune Reconstitution In Six Adolescents With Chronic Granulomatous Disease (CGD) Following Hematopoietic Stem Cell Transplant (HSCT)
145. Using electronic medical record data to report laboratory adverse events
146. Comparative Effectiveness of Cidofovir Preemptive Therapy for Human Adenovirus Infection in Pediatric Hematopoietic Cell Transplant Recipients
147. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
148. The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia
149. Low rates of pregnancy screening in adolescents before teratogenic exposures in a national sample of children's hospitals
150. Early discharge as a mediator of greater ICU ‐level care requirements in patients not enrolled on the AAML 0531 clinical trial: a Children's Oncology Group report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.